Our data therefore highlight that variations in underlying maternal insulin secretion and sensitivity together with the degree of metabolic stress posed by factors specific to the pregnancy, all contribute to variations in postpartum risk for glucose intolerance. The gene discussed is INS; the disease is Glucose intolerance.